How many insider declarations has Pauling David filed?

Pauling David has filed 3 public insider declarations with SEC (Form 4).

What is Pauling David's role?

Pauling David's reported role is not specified by the regulator across the filings.

Which companies does Pauling David report trades for?

Pauling David reports trades for Sutro Biopharma, INC..

What is Pauling David's declared buy vs sell volume?

Across the available history, declared buys total 9k€ and disposals 0.

← Executives ★ Sign in to follow

PD

Pauling David

M

·SEC (Form 4)

Sutro Biopharma, INC.

0

申报总数

0

公司

€8,581

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+29.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Pauling David. Officer active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 15 October 2025. The latest transaction was filed on 4 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Pauling David

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Sutro Biopharma, INC. (US)

申报3 总计

◇

Pauling David

Chief Admin. Ofcr. & GC高管2026年3月4日Sutro Biopharma, INC.

0SEC ↗

675 股0Common StockSEC:0002063633-26-000003:0

◇

Pauling David

Chief Admin. Ofcr. & GC高管2026年3月1日Sutro Biopharma, INC.

0SEC ↗

500 股0Common StockSEC:0002063633-26-000002:0

▲

Pauling David

Chief Admin. Ofcr. & GC高管2025年10月15日Sutro Biopharma, INC.

US$9,99341SEC ↗

12,504 股@ US$0.7992100.0% 占其流量Common StockSEC:0002063633-25-000004:0

标准退出：2026年1月13日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PD

Pauling David

M

·SEC (Form 4)

Sutro Biopharma, INC.

0

申报总数

0

公司

€8,581

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+29.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Pauling David. Officer active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 15 October 2025. The latest transaction was filed on 4 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.